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Abstract
Background: A number of surveys have examined use of complementary and alternative
medicines (CAM) in Australia. However, there are limited Australian data on use of CAM and over-
the-counter (OTC) medicines in the elderly population. The main aims of this study were to
examine self-medication practices with CAM and OTC medicines among older Australians and
variables associated with their use.
Methods: The Australian Longitudinal Study of Ageing (ALSA) is an ongoing multidisciplinary
prospective study of the older population which commenced in 1992 in South Australia. Data
collected in 4 waves of ALSA between 1992 and 2004 were used in this study with a baseline sample
of 2087 adults aged 65 years and over, living in the community or residential aged care. OTC
medicines were classified according to the World Health Organization Anatomical Therapeutic
Chemical (ATC) classification. CAM were classified according a modified version of the
classification adopted by the Therapeutics Goods Administration (TGA) in Australia.
Results: The prevalence of CAM or OTC use ranged from 17.7% in 2000-2001 to 35.5% in 2003-
2004. The top classes of CAM and OTC medicines used remained relatively constant over the
study period. The most frequent classes of CAM used were vitamins and minerals, herbal medicines
and nutritional supplements while the most commonly used OTC were analgesics, laxatives and
low dose aspirin. Females and those of younger age were more likely to be CAM users but no
variable was associated with OTC use.
Conclusion: Participants seemed to self-medicate in accordance with approved indications,
suggesting they were informed consumers, actively looking after their own health. However, use
of analgesics and aspirin are associated with an increased risk of adverse drug events in the elderly.
Future work should examine how self-medication contributes to polypharmacy and increases the
risk of adverse drug reactions.
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In Australia, the proportion of adults over the age of 65 in
2005 was 13% and this figure is expected to more than
double by 2051. South Australia has the highest percent-
age of people aged 65 and over of all Australian states and
territories, and this age group is expected to make up
26.5% of the state's population by 2031[1].
Increasing age is associated with increased prevalence of
chronic medical conditions [2], a higher number of med-
icines used, and a higher demand for all medical services,
including alternative services [3,4]. High levels of self-
medication practices with over-the-counter (OTC) medi-
cines and complementary and alternative medications
(CAM) have been reported in Australia and comparable
countries [5-9]. The most extensive survey of the South
Australian population in 2004 found that CAMs were
used by 52.2% of the respondents with the greatest use in
better-educated, higher income, women in the 25-44
years of age group living in a metropolitan area [6]. Use of
OTC drugs and CAM in the elderly is of particular interest
because several variables associated with old age such as
polypharmacy, multiple comorbid illnesses and physio-
logical changes, can increase the risk of adverse drug reac-
tions. Most research on use of CAM and OTC medicines
has focused on groups of people with specific chronic
conditions. The use of CAM and OTC drugs in the general
elderly population remains under-studied internation-
ally.
The Australian Longitudinal Study of Ageing (ALSA) is an
ongoing multidisciplinary prospective study of the older
population which commenced in 1992 in South Aus-
tralia. People initially recruited in the study were re-inter-
viewed at multiple time points and ten waves of data
collection have been carried out to date. An earlier assess-
ment showed that, at baseline, more than one quarter of
the participants were taking at least five medications con-
currently [10]. One third of the participants were using
non-prescription medications in combination with pre-
scribed medicines. Our study aimed to examine self-med-
ication practices among older Australians, to ascertain the
most commonly used non-prescription medications and
variables shown in previous research to be associated with
their use (i.e. age, gender, education, income and health).
Methods
ALSA data were used in this study. Methods for inclusion
of subjects and survey tools have been described in detail
previously [10]. In brief, subjects aged 65 years and over
were randomly drawn from the South Australian Electoral
Roll. The sample was stratified by age and gender. In this
report, 'age' is dichotomized as 65-79 years or more than
80 years of age. Categories for the other background vari-
ables of interest are shown in Table 1. Comprehensive
personal interviews were performed in wave 1 (1992-
1993), wave 3 (1994-1995), wave 6 (2000-2001) and
wave 7 (2003-2004). Participants were asked about all
medicines that they had taken or were supposed to take in
the last two weeks. For each medicine, the drug name,
dose, duration of treatment, indication for use, whether it
was prescribed by a doctor and the reason for use was
asked. Reasons for use were grouped a posteriori into cat-
egories specific to the type of products. Participants were
also asked to show the medicine container to the inter-
viewer.
OTC medicines were classified according to the World
Health Organization Anatomical Therapeutic Chemical
(ATC classification). Self-reported OTC medicines
belonged to ten ATC categories: analgesics, laxatives, anti-
thrombotic agents, antacids, cough and cold preparations,
antihistamines, dermatologicals, throat preparations,
nasal preparations and antidiarrhoeals. CAM were classi-
fied according to the classification adopted by the Thera-
peutics Goods Administration (TGA) in Australia [11].
The TGA classification was modified to exclude aromath-
erapy products (no reports) and to include two additional
categories, probiotics and combination products to
account for those medicines containing multiple ingredi-
ents that fell into different classes of CAM. The final CAM
classification included seven categories: herbal medicines,
traditional medicines (products identified as those used
in a specific traditional medical system such as Traditional
Chinese Medicine), vitamins and minerals, nutritional
supplements, homeopathic medicines, probiotics and
combination products.
The most common variables associated with use of CAM
or OTC medicines were identified through a literature
review of relevant studies published between 1985 and
2007. Relevant variables available in the ALSA dataset
included age, gender, education level, income level and
self-rated health. Pearson's chi-square tests were carried
out to determine the statistical significance of the associa-
tion between use of CAM and OTC medicines and the var-
iables selected. Data were analysed using the Statistical
Package for Social Sciences (SPSS) version 14.0. This study
was approved by the Ethics Committee of the University
of South Australia.
Results
Characteristics of participants
A baseline sample of 2087 participants was interviewed in
wave 1 with 1679, 791 and 487 participants re-inter-
viewed in waves 3, 6 and 7 respectively. Attrition was
mainly due to mortality (58.7% at wave 7) and refusal to
participate (13.6% at wave 7), the latter most often due to
frailty and ill-health.Page 2 of 10
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men and women and 84% reported leaving school at age
fourteen or over. The percentage of female participants
increased from 49.4% in 1992-1993 to 62.2% in 2003-
2004. The percentage of participants over the age of 80
years increased from 41.4% in the 12-year period between
1992-1993 to 90.3% in 2003-2004 [Table 1]. Across the
waves, the majority of participants rated their own health
as good, very good or excellent and about of third of par-
ticipants rated their health as fair or poor [Table 1].
Prevalence of self-medication
The range of participants reporting using either at least
one CAM or one OTC medicine varied from 19.4% in
1992-1993 to 35.5% in 2003-2004 [Table 2]. Corre-
spondingly, when examined separately, the use of CAM
and OTC medicines varied from 12.8% to 17.0%, and
8.6% to 24.2% respectively over this time period.
Top classes of CAM and OTC use were relatively constant
across the waves [Table 3]. Vitamins and minerals were
Table 1: Characteristics of participants at waves 1, 3, 6 and 7
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 2087 Wave 3 N = 1679 Wave 6 N = 791 Wave 7 N = 487
Variable N % N % N % N %
Age (years)
65-79 1224 58.6 893 53.2 216 27.3 47 9.7
80+ 863 41.4 786 46.8 575 72.7 440 90.3
Gender
Female 1031 49.4 854 50.9 456 57.6 303 62.2
Male 1056 50.6 825 49.1 335 42.4 184 37.8
Education
(Age when left school)
<14 years 336 16.3 262 15.4 105 13.3 65 13.4
≥ 14 years 1725 83.7 1399 84.6 684 86.7 420 86.6
Missing 26 18 2 2
Tertiary education
Yes 700 33.9 570 34.2 278 35.2 177 36.5
No 1367 66.1 1096 65.8 512 64.8 308 63.5
Missing 20 13 1 2
Income Level
<$12,000 686 35.5 559 40.9 165 30.3 116 35.6
$12,000 - $30,000 1083 56.1 719 52.6 312 57.4 146 44.8
>$30,000 161 8.3 90 6.6 67 12.3 64 19.6
Missing 157 311 247 161
Self-rated health
Excellent 191 9.2 129 8.2 64 9.8 16 3.9
Very Good 599 28.8 410 25.9 181 27.7 85 20.5
Good 633 30.4 534 33.8 224 34.3 171 41.2
Fair 477 22.9 403 25.5 147 22.5 113 27.2
Poor 181 8.7 106 6.7 37 5.7 30 7.2
Missing 6 97 138 72
Missing data are not included in the calculation of the percentages
Table 2: Number of participants using either CAM and OTC medicines
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 2087 Wave 3 N = 1679 Wave 6 N = 791 Wave 7 N = 487
Variable N % N % N % N %
CAM or OTC1 404 19.4 460 27.4 140 17.7 173 35.5
OTC only 268 12.8 278 16.6 79 10.0 83 17.0
CAM only 180 8.6 241 14.4 71 9.0 118 24.2
1 Users of either one CAM or OTC medicine.Page 3 of 10
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(5.4% to 14.0%). This was followed by herbal medicines
(2.4% to 5.5%) and nutritional supplements (1.6% to
7.6%). Most of the combination products (2.1% to 5.1%)
included different herbal combinations. Multivitamins
and vitamin C were the most commonly used vitamins.
Garlic, celery and gingko biloba were the most commonly
used herbal medicines and cod liver oil was the most pop-
ular nutritional supplement [Table 4].
Analgesics were the most common class of OTC drugs at
all waves (5.4 to 8.8%), followed by laxatives (2.0% to
5.1%) and antithrombotic agents (low dose aspirin)
(1.6% to 2.6%). The most commonly used analgesic was
Table 3: Prevalence of use of CAM and OTC medicines
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 2087 Wave 3 N = 1679 Wave 6 N = 791 Wave 7 N = 487
Classes of CAM/OTC N % N % N % N %
CAM Vitamins & minerals 113 5.4 155 9.2 53 6.7 68 14.0
Herbal medicines 50 2.4 69 4.1 23 2.9 27 5.5
Nutritional supplements 34 1.6 54 3.2 26 3.3 37 7.6
Homeopathic medicines 4 0.2 5 0.3 0 0.0 1 0.2
Probiotics 3 0.1 4 0.2 0 0.0 0 0.0
Combination products 43 2.1 49 2.9 9 1.1 25 5.1
OTC Analgesics 112 5.4 127 7.6 44 5.6 43 8.8
Laxatives 89 4.3 76 4.5 16 2.0 25 5.1
Antithrombotic agents 34 1.6 43 2.6 17 2.1 10 2.1
Antacids 19 0.9 14 0.8 1 0.1 6 1.2
Cough & cold preps 16 0.8 18 1.1 0 0.0 5 1.0
Antihistamines 7 0.3 4 0.2 2 0.3 1 0.2
Dermatologicals 3 0.1 4 0.2 1 0.1 0 0.0
Throat preparations 4 0.2 0 0.0 0 0.0 0 0.0
Nasal preparations 2 0.1 5 0.3 0 0.0 0 0.0
Antidiarrhoeals 2 0.1 1 0.1 0 0.0 0 0.0
Other1 11 0.5 16 1.0 4 0.5 4 0.8
Unknown2 11 0.5 10 0.6 3 0.4 12 2.5
The percentages show the proportions of participants reporting to use at least one of the classes of CAM or OTC medicines
1 Other CAM and OTC classes that were less commonly reported
2 Non-prescription medicines of unknown ingredients that could not be classified
Table 4: Most commonly used CAM
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 180 Wave 3 N = 241 Wave 6 N = 71 Wave 7 N = 118
CAM N % N % N % N %
Vitamins and minerals
Multivitamins 40 22.2 57 23.7 22 31 33 28
Vitamin C 32 17.8 47 19.5 8 11.3 23 20.3
Vitamin B 19 10.6 31 12.9 8 11.3 5 4.2
Vitamin E 18 10 43 17.8 16 22.5 9 7.6
Herbal medications
Garlic 24 13.3 22 9.1 3 4.2 2 1.7
Celery 13 7.2 18 7.5 3 4.2 1 0.8
Gingko biloba 2 1.1 5 2.1 10 14.1 9 7.6
Nutritional supplements
Cod liver oil 22 12.2 37 15.4 9 12.7 11 9.3
Fish oil 6 3.3 5 2.1 3 4.2 8 6.8
Glucosamine 0 0 0 0 4 5.6 10 8.5
The percentages are calculated over the number of participants that reported use of at least one CAM indicated as NPage 4 of 10
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or a mixture of both.
Variables affecting self-medication
OTC use was not associated with age, gender, education
level and tertiary education in any of the four waves [Table
5]. Although there was a statistically significant associa-
tion between income and OTC use in waves 3 and 6, the
pattern of results was inconsistent for the different waves.
The same was true for self-rated health.
CAM use was associated with age and gender [Table 6].
The younger elderly people were more likely to use CAM
than the older group (80 years and over) in all four waves.
The difference in use remained constant over time, with
those age 65 to 79 years old being 1.5 to 1.6 times more
likely to use CAM than those aged 80 years or more.
Females were also found to be more likely users of CAM
in waves 1, 3 and 6 (the results were not statistically sig-
nificant in wave 7). CAM use was not associated with edu-
cation level, tertiary education, income level and self-
rated health in any wave except in wave 7 where use of
CAM was higher in participants with tertiary education.
Reasons for using CAM and OTC medicines
The main reasons for using analgesics were headache and
pain (Table 7). Low dose aspirin was reported to be used
for blood thinning and/or stroke prevention by most par-
ticipants (Table 8). However, some respondents reported
unlikely reasons for use such as for lowering cholesterol
levels, hypertension and for sleep.
The most common reasons for use of multivitamins were
supplementation and maintenance of general health
(Table 9). Vitamin C was predominantly used to ward off
colds, to boost the immune system and for general health
maintenance across all four waves (Table 10).
Discussion
Up to a third of older participants in the current study
used either CAM or OTC medicines. The study differed
from Australian studies conducted earlier in several ways
Table 5: Prevalence of OTC use across variables of interest
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 268 Wave 3 N = 278 Wave 6 N = 79 Wave 7 N = 83
Variable N % N % N % N %
Age (years)
65-79 159 13.0 148 16.6 27 12.5 8 17.0
80+ 109 12.6 130 16.5 52 9.0 75 17.0
P value 0.809 0.985 0.149 0.997
Gender
Female 146 14.2 149 17.4 52 11.4 51 16.8
Male 122 11.6 129 15.6 27 8.1 32 17.4%
P value 0.075 0.318 0.121 0.873
Education
(Age when left school)
<14 years 47 14.0 47 17.9 14 13.3 11 16.9
≥ 14 years 220 12.8 227 16.2 65 9.5 72 17.1
P value 0.538 0.493 0.223 0.965
Tertiary education
Yes 98 14.0 101 17.7 27 9.7 31 17.5
No 170 12.4 176 16.1 52 10.2 52 16.9
P value 0.316 0.388 0.843 0.859
Income Level
<$12,000 89 13.0 97 17.4 26 15.8 23 19.8
$12,000 - $30,000 137 12.7 111 15.4 26 8.3 24 16.4
>$30,000 25 15.5 27 30.0 5 7.5 8 12.5
P value 0.598 0.003 0.029 0.446
Perceived Health
Excellent 19 9.9 17 13.2 4 6.3 4 25.0
Very Good 63 10.5 58 14.1 25 13.8 13 15.3
Good 96 15.2 105 19.7 21 9.4 25 14.6
Fair 73 15.3 73 18.1 18 12.2 24 21.2
Poor 17 9.4 14 13.2 4 10.8 6 20.2
P value 0.018 0.097 0.438 0.536
The percentages are calculated over the total number of participants in each category of the variable of interestPage 5 of 10
(page number not for citation purposes)
BMC Complementary and Alternative Medicine 2009, 9:42 http://www.biomedcentral.com/1472-6882/9/42
Page 6 of 10
(page number not for citation purposes)
Table 6: Prevalence of CAM use across variables of interest
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 180 Wave 3 N = 241 Wave 6 N = 71 Wave 7 N = 173
Variable N % N % N % N %
Age (years)
65-79 122 10.0 152 17.0 27 12.5 17 36.2
80+ 58 6.7 89 11.3 44 7.7 101 23.0
P value 0.009 0.001 0.034 0.044
Gender
Female 102 9.9 142 16.6 53 11.6 81 26.7
Male 78 7.4 99 12.0 18 5.4 37 20.1
P value 0.041 0.007 0.002 0.098
Education
(Age when left school)
<14 years 30 8.9 39 14.9 10 9.5 16 24.6
≥ 14 years 149 8.6 200 14.3 61 8.9 102 24.3
P value 0.862 0.803 0.840 0.954
Tertiary education
Yes 63 9.0 92 16.1 27 9.7 56 31.6
No 116 8.5 149 13.6 44 8.6 62 20.1
P value 0.694 0.161 0.600 0.004
Income Level
<$12,000 52 7.6 82 14.7 18 10.9 33 28.4
$12,000 - $30,000 101 9.3 120 16.7 29 9.3 34 23.3
>$30,000 12 7.5 13 14.4 10 14.9 12 18.8
P value 0.385 0.581 0.385 0.326
Self-rated health
Excellent 16 8.4 17 13.2 12 18.8 7 43.8
Very Good 58 9.7 64 15.6 17 9.4 24 28.2
Good 56 8.8 90 16.9 23 10.3 43 25.1
Fair 38 8.0 53 13.2 11 7.5 23 20.4
Poor 12 6.6 11 10.4 5 13.5 6 20.0
P value 0.722 0.312 0.152 0.268
The percentages are calculated over the total number of participants in each category of the variable of interest
Table 7: Reasons for use of analgesics
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 112 Wave 3 N = 127 Wave 6 N = 44 Wave 7 N = 43
Reasons of use of analgesics N % N % N % N %
Headache 35 31.8 41 32.3 5 11.4 6 14
Specific pain 19 17.3 16 12.6 4 9.1 5 11.6
General pain 18 16.4 26 20.5 25 56.8 22 51.2
Other 21 19.1 25 19.7 5 11.4 3 7.0
Arthritic pain 11 10.0 15 11.8 2 4.5 4 9.3
Multiple reasons 6 5.5 4 3.1 3 6.8 3 7.0
Missing 2 0 0 0
The percentages are calculated over the number of participants that reported use of analgesics
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tion, namely elderly people aged 65 and older in South
Australia. The study also sought to provide a broader
insight into the self-medication practices of the elderly in
examining use of both CAM and OTC medicines and rea-
sons for use.
Fewer elderly people in our survey reported use of OTC
medicines (10% to 17%) compared to a range of 31% to
97% in other surveys [15-19]. However, these surveys
were carried out in the United States (US). The discrepan-
cies observed may be explained by differences in the defi-
nition of OTC medicines and differences in subsidised
accessibility to prescription medicines between Australia
and the US. Non-prescription vitamins and minerals are
considered as OTC medicines by the US Food and Drug
Administration (FDA) and CAM by the TGA [11,20]. Fur-
thermore, there is no national subsidisation scheme for
pharmaceuticals in the US while in Australia, residents
may prefer to get most medicines on prescription due to
low co-payment fees. This is particularly relevant for med-
icines such as paracetamol which is widely used in both
countries and which is available as a subsidised prescrip-
tion medicine only in Australia.
The reported use of CAM (8.6% to 24.2%) in our study
was lower than in previous Australian studies (37% to
58%) [6,14,21-23]. Several differences in the methods
used may account for this variation. All but two of the pre-
vious studies included alternative services such as acu-
puncture, massage and chiropractic in their definition of
CAM. The time interval over which participants reported
has also varied. A 2004 survey in South Australia found
37% of people older than 65 years were CAM users but
participants were asked whether they had used any CAM
over the past year [6]. A study with a similar definition of
use to this current study in terms of time interval and
products surveyed reported 43% of CAM use [21]. How-
ever, the format of the interview where examples of each
type of supplement were provided may have prompted
more reports of CAM use [21]. A recent study in Iceland
was conducted using similar methods to ALSA where
simultaneous recording of herbal and dietary supple-
ments (HADS) and prescription medicine use was carried
out [24]. This study reported a prevalence of 80% of
HADS use among their participants.
The top three classes of OTC drugs used by our respond-
ents did not change between 1992 and 2004 and were
similar to those described previously in the 1989-1990
Australian National Health Survey [25]. Analgesics were
the most commonly used class of OTC medicines, pre-
dominantly paracetamol. Painful chronic conditions are
prevalent in the elderly and therefore, many are amenable
to treatment by OTC analgesics. Other international stud-
ies have also found analgesics to be the most commonly
reported OTC class, though aspirin and non-steroidal
anti-inflammatory drugs (NSAIDs) were more commonly
used than paracetamol [7,15,18,19]. It is unclear whether
in these studies all aspirin use was grouped under analge-
Table 8: Reasons for use of antithrombotic agents
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 34 Wave 3 N = 43 Wave 6 N = 17 Wave 7 N = 10
Reasons of use of antithrombotic agents N % N % N % N %
Blood thinning &/or stroke prevention 27 87.0 36 85.7 16 94.1 6 60.0
Unlikely reasons 4 12.9 5 11.6 1 5.9 4 40.0
Other 0 0.0 1 2.3 0 0.0 0 0.0
Missing 3 1 0 0
The percentages are calculated over the number of participants that reported use of antithrombotic agents
Table 9: Reasons for use of multivitamins
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 40 Wave 3 N = 57 Wave 6 N = 22 N = 22 Wave 7 N = 33
Reasons of use of multivitamins N %1 N %1 N %1 N %1
Supplement 19 47.5 22 38.6 1 4.5 8 24.2
General health 14 35.0 27 47.4 21 95.5 19 57.6
Energy boost or tiredness 4 10.0 3 5.3 0 0.0 1 3.0
Other1 3 7.5 5 8.8 0 0.0 5 15.1
The percentages are calculated over the number of participants that reported use of multivitamins
1 Other reasons included nerves or stress, arthritis, cold prevention and immune stimulation and multiple reasonsPage 7 of 10
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used at low dose as an antiplatelet agent or at a higher
dose as an analgesic agent based on the medicine strength
and indication of use. Low dose aspirin was found to be
the third most commonly reported class of OTC drugs in
our study.
Vitamins and minerals, herbal medicines and nutritional
supplements were the three most common classes of CAM
reported across all waves. This is consistent with findings
reported in other Australian studies [9,21,22]. Multivita-
mins accounted for about one-third of all CAM used
across the waves, followed by Vitamins C, B and E in
agreement with the results of previous studies [21-26].
The most common herbal product to be reported in this
study was garlic, also in agreement with other studies
[21,26], with gingko biloba, marketed for age-related
memory impairment, gaining popularity in the latest
waves. Cod liver oil was the most popular nutritional sup-
plement across all waves, with glucosamine use emerging
as a treatment for arthritis after 2001, consistent with
Brownie's prediction in 2000 [21]. One reason for the
more recent emergence of this product in the study may
be the shift towards inclusion of this product as part of
conventional care.
None of the demographic variables tested, age, gender,
education, tertiary education, income level and self-rated
health was found to be associated with OTC use. The rela-
tionship of age and OTC use is equivocal in the literature
[7,16,27,28]. Greater OTC use was observed in females in
the US studies that included multivitamin use
[7,16,27,28]. Greater educational attainment and poorer
self-rated health have been associated with higher use of
OTC in some studies [15,16,27].
Female gender and a younger age were the only variables
found to be associated with CAM use in our study, in
agreement with previous studies [12,14,15,21,23,26,29].
Possible explanations for CAM use were not available in
the data because ALSA participants were not asked about
attitudinal or psychological factors involved in their
choice of medicines. A literature review of variables
reported to influence the use of complementary medi-
cines by consumers suggested that the emergence of post-
modern values provided the best explanation of
consumers' interest in CAM[9]. Postmodern values
involved "a new set of beliefs about nature, science, holis-
tic medicine, rejection of authority, individual responsi-
bility and consumerism" [9]. A recent survey of attitudes
of Australian consumers to complementary medicines
found that many consumers saw their CAM use as "natu-
ral" and part of a holistic view of health [30].
Reasons reported for using OTC medicines were consist-
ent with the indications approved by the Australian med-
icines agency with the exception of low-dose aspirin for
which between 5.9% and 40.0% of participants reported
unlikely reasons. The most common reasons for use of
multivitamins were supplementation and maintenance of
general health. In a 2004 Australian study that examined
beliefs in CAM users, most respondents had no specific
medical reason for using CAM but believed they would
help their general health. Promotion of general health
and prevention of illness were also found the main varia-
bles driving the use of CAM in other international studies
[9]. Some CAM could also be used for the treatment of
symptoms such as glucosamine for arthritis.
There were some potential limitations to our study.
Although there was an apparent overall increase of partic-
ipants reported use of at least one CAM or OTC from
19.4% at baseline to 35.5% by 2004, we did not attempt
to assess statistically the time trend given the large amount
of missing data due to the high attrition level at wave 7.
Furthermore, slight variations in medication data collec-
tion methods in waves 3 and 7, and a higher proportion
of women in wave 7 could partly explain the higher use of
CAM and OTC medicines observed at this wave. Although
many of the ALSA participants were from non-English
speaking backgrounds, fluent English was essential and
thus, the findings may not be a true reflection of the use
Table 10: Reasons for use of vitamin C
1992-1993 1994-1995 2000-2001 2003-2004
Wave 1 N = 32 Wave 3 N = 47 Wave 6 N = 8 Wave 7 N = 23
Reasons of use of Vitamin C N % N % N % N %
Cold prevention and immune stimulation 13 43.3 14 30.4 0 0.0 8 34.8
General health 7 23.3 18 39.1 8 100 8 34.8
Supplement 6 20.0 7 15.2 0 0.0 3 13.0
Other1 4 13.3 7 15.2 0 0.0 4 17.4
Missing 2 1 0 0
The percentages are calculated over the number of participants that reported use of Vitamin C
1 Other reasons included muscles or bones, energy boost or tiredness, blood or circulation, arthritis, cardiac or heart health and multiple reasonsPage 8 of 10
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nity in a multi-cultural country. Finally, but like most
other studies, the data we gathered was self-reported.
However, unlike other studies, respondents were asked to
show the medicine containers, even so some medicines
could have been overlooked. The reasons for use of CAM
were categorized from self-reported reasons by consumers
and the categories were set up to reflect as closely as pos-
sible the words used by the consumers themselves. Then,
it is not possible to infer from this data whether use of
CAM for "general health" or as "supplement" reflect dif-
ferent beliefs as regards the therapeutic effect of CAM. The
question of whether consumers perceived themselves to
be "deficient" in a vitamin or believe that supra-therapeu-
tic doses would improve physical or mental performance
cannot be determined from the data collected in the ALSA
database.
This study focused on examining the types of non-pre-
scription medications used by older Australians and the
association between use and various demographic and
health-related factors. Further work is needed to examine
how self-medication amongst older people contributes to
polypharmacy and increases the risk of adverse drug reac-
tions. Use of NSAIDs and aspirin, for example, are associ-
ated with an increased risk of adverse drug events,
hospitalization and death, with the elderly being particu-
larly vulnerable [31]. Some OTC medicines may also have
severe interactions with prescribed medicines [32].
Conclusion
Self-medication among the ALSA respondents ranged
from 18% to 36% between 1992 and 2004. The most fre-
quent classes of CAM were vitamins and minerals, herbal
medicines and nutritional supplements, with younger
individuals and women more likely to use them. For OTC
medicines, the most commonly used were analgesics, lax-
atives and low dose aspirin. Use of OTC medicines
seemed to be done in accord with indications officially
approved by the Australian medicine agency. Future work
should examine risks associated with the concomitant use
of CAM, prescription and OTC medicines.
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